BGM Group Ltd. BGM
NASDAQ BGM
$9.40 +1.16 (+14.07%)
As of: Oct 22, 2026 · 10:27 AM EDT

Bgm (BGM) Receivables - Other (2019 - 2025)

Updated

Bgm (BGM) recorded Receivables - Other of $349,314 in fiscal Q4 2025 (quarter ended Sep 30, 2025), up 81.6% from $192,387 a year earlier.

Analysis

Bgm (BGM) Receivables - Other (2019 - 2025) Analysis & Trends

Starting with fiscal Q4 2019, Bgm's Receivables - Other history includes 11 quarters.

  • Annual Receivables - Other has a five-year compound annual growth rate of 63.4% (FY2020 to FY2025).
  • Across earlier fiscal years, Receivables - Other came in at $192,387 in FY2024 (-22.3%), $247,481 in FY2023 (-83.2%), $1.47 million in FY2022 and $17,318 in FY2021 (-42.2%).
  • Quarterly Receivables - Other has ranged from -$16,103 in fiscal Q2 2021 to $1.47 million in fiscal Q4 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn
10 Bgm 36.66 Mn -18.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 9.18 Mn
Mar 31, 2025 377,110.00
Sep 30, 2024 192,387.00
Mar 31, 2024 129,612.00
Sep 30, 2023 247,481.00
Sep 30, 2022 1.47 Mn
Mar 31, 2022 9,802.00
Sep 30, 2021 14,090.00
Mar 31, 2021 -16,103.00
Sep 30, 2020 8,126.00
Sep 30, 2019 59,953.00
API Access

Bgm Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BGM&period=max&api_key=YOUR_API_KEY